---

$1.07

+0.0500 ( +4.90% ) 0.9K

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Open	$1.07
Previous Close	$1.02
Volume	0.9K
Market Cap	$129.74M
Day Range	$1.04 - $1.08
52 Week Range	$0.78 - $4.98
Shares Outstanding	127.19M
Change %	+4.90%
Net Change	▲ 0.0500
Insider Ownership	-0.03%
Exchange	NYSE
Sector	Miscellaneous
Industry	None
IPO Year	2020
Country	United States
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-09	Buy	56900.00	Redmile Group, LLC